Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Leukotrienes B4 and C4 in MS.

M Prosiegel, I Neu, A Wildfeuer

    Acta Neurologica Scandinavica
    |May 1, 1987
    PubMed
    Summary

    Multiple sclerosis patients show reduced leukotriene C4 (LTC4) release from neutrophils, suggesting a potential role in disease pathogenesis. Leukotriene B4 (LTB4) release remained unchanged in these patients.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    [Management of dysphagia in acute stroke : A prospective study for validation of current recommendations].

    Der Nervenarzt·2017
    Same author

    [FEES for neurogenic dysphagia: training curriculum of the German Society of Neurology and the German Stroke Society].

    Der Nervenarzt·2014
    Same author

    Long-term functional outcome in patients with neurogenic dysphagia.

    NeuroRehabilitation·2014
    Same author

    [FEES in the stroke unit: recommendations for implementation in the clinical routine].

    Der Nervenarzt·2013
    Same author

    [Management of dysphagic patients with acute stroke].

    Der Nervenarzt·2012
    Same author

    Pneumonia and in-hospital mortality in the context of neurogenic oropharyngeal dysphagia (NOD) in stroke and a new NOD step-wise concept.

    Journal of neurology·2010

    Area of Science:

    • Neuroimmunology
    • Inflammation Research
    • Leukotriene Biology

    Background:

    • Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system.
    • Leukotrienes are key mediators in inflammatory processes.
    • Dysregulation of inflammatory mediators may contribute to MS pathology.

    Purpose of the Study:

    • To investigate the release of leukotriene B4 (LTB4) and leukotriene C4 (LTC4) in multiple sclerosis (MS) patients.
    • To compare leukotriene release between MS patients and healthy controls.

    Main Methods:

    • Quantified leukotriene B4 (LTB4) and leukotriene C4 (LTC4) release from neutrophils and platelet-neutrophil suspensions.
    • Stimulation was induced using ionophore A23187.
    • Study included 12 MS patients and 8 healthy volunteers.

    Main Results:

    • Significantly decreased leukotriene C4 (LTC4) release was observed in MS patients compared to controls.
    • No significant difference in leukotriene B4 (LTB4) release was found between MS patients and controls.
    • Findings suggest potential depletion of precursors for 5-lipoxygenase products in MS.

    Conclusions:

    • Reduced LTC4 release in MS patients may indicate altered inflammatory mediator production.
    • The findings suggest a potential pathogenetic role for LTC4 in the formation of MS lesions.
    • Further research into leukotriene metabolism in MS is warranted.

    Related Experiment Videos